Gabriel Monagas, MD
Vascular & Interventional Radiology · Mayaguez, PRNPI 1184895005
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Bard Access Systems, Inc. at 26.2% of the total. Reporting peaked in 2019 at $291 and has fallen 85.7% since, to $42 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in PR, where the typical reported total is $975.
Across 20 payments — averaging $41.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Access Systems, Inc.$215
- Bard Peripheral Vascular, Inc.$131
- Genentech USA, Inc.$125
- BD$107
- Cordis US CORP.$64
- Boston Scientific$52
- plus $126 from 3 others
What the payments were for
- Food & beverage$820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Access Systems, Inc. | 2 | $215 |
| Bard Peripheral Vascular, Inc. | 3 | $131 |
| Genentech USA, Inc. | 1 | $125 |
| BD | 5 | $107 |
| Cordis US CORP. | 3 | $64 |
| Boston Scientific | 2 | $52 |
| Medtronic | 2 | $50 |
| Johnson & Johnson | 1 | $39 |
| Davol Inc. | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$125
How this compares
$820 in reported general payments places this provider in the 40th percentile of 27 vascular & interventional radiology providers in Puerto Rico.
See all vascular & interventional radiology providers in Puerto Rico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 29 | $124 |
| Metronidazole | 19 | $65 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Mayaguez
- Stephanie Torres-AyalaMayaguez$7K
- Angel Torres RiveraMayaguez$4K
- Roberto LatoniMayaguez$60
- Carlos AnayaManati$18K
- Eduardo Gonzalez PonsManati$8K
- Roberto Kutcher-DiazSan Juan$6K
- Manuel Betancourt TorresLuquillo$3K
- Jesus BuonomoPonce$2K
- Alejandro Hidalgo RiosSan Juan$2K
- Brandon PaganDorado$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.